Pfizer announced Monday that trials showed its COVID-19 vaccine to be safe and elicited a “robust” antibody response in children ages 5 to 11. These are the first known results of its kind for a COVID-19 vaccine in this age group in the US The data, however, has not yet been peer-reviewed or officially published. However, Pfizer plans to soon submit the documents to the US Food and Drug Administration to request an emergency use authorization for minors.
Posted at 18:41 ET (22:41 GMT) Wednesday, October 27, 2021 Playing 0:59 Posted at 17:27 ET (21:27 GMT) Monday,...
Young Trump supporter charged with murder 3:32 (Trends Wide) -- The men Kyle Rittenhouse shot in August 2020 could...
DC Trails, an interstate bus fleet company, lost about 60 employees to the pandemic. Profits have fallen by US...
"I am really excited and optimistic that we will be able to implement vaccines for 28 million children between...
This is how the fatal shot would have happened on the set of "Rust" 0:40 (Trends Wide) -- The...
Breaking News & Latest News, US news - Product Reviews
Contact Email: souhaib@trendswide.com
